UPLC Therapeutic Peptide Method Development Kit

Part Number: 176001835
Manufacturer: Waters
|
Delivery Time: approx. 5 days (product only available in Germany)
Excl. 19% taxes, excl. Shipping costs
Packaging unit: 1 pc, Minimum order quantity: 1 pc
Product Line

Questions, MSDS, CoA?

Do you have any questions? Give us a call or send us an email!

Product Description

UPLC Therapeutic Peptide Method Development Kit

Features and Benefits

  • UHPLC particles
  • BEH, CSH, and HSS particle technologies for broad selectivity
  • High reproducibility
  • Wide range of phases for method development and routine analysis
  • Suitable for pharmaceutical, biopharmaceutical, environmental, food, and research applications

Additional Information

The Waters ACQUITY series includes sub-2-µm UPLC phases based on hybrid particles, high-strength silica, and charged-surface hybrid materials. BEH particles consist of an organic-inorganic hybrid matrix and offer high chemical and mechanical stability. HSS particles provide silica-like selectivity with high pressure stability, while CSH particles enable particularly good peak shapes for basic analytes in LC-MS-friendly mobile phases thanks to a controlled surface charge. Compatible VanGuard or Guard systems protect the main column from matrix components.

Legal Notices

ACQUITY is a registered trademark of Waters Corporation, Milford, Massachusetts, USA.

Product Specification

Brand ACQUITY
Product Type (U)HPLC Column Kit
Length 50 mm
Internal Diameter 2.1 mm
Particle Size 1.7 µm
Chemistry C18 (RP-18, ODS, Octadecyl)
Chemistry Producers Term C18
Pore Size 300 Ã…
USP Class L1
Carbon Load 18.0 %
Endcapping endcapped
Country of Origin United States of America (USA)
Column Type Analytical Column
Hardware Material Stainless Steel
Hardware Type Ready-to-use Column
pH Minimum 1.0
pH Maximum 12.0
Mode of Separation Reversed Phase Chromatography (RP)
Technology U(H)PLC
Matrix Hybrid
Particle Morphology spherical, fully porous

Support - Downloads